A carregar...
Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study
BACKGROUND: Regorafenib is a multi-kinase inhibitor approved for treatment of refractory advanced colorectal cancer. It was found in the clinical trials to have a modest benefit and significant toxicity. Our aim was to assess the outcome in our local clinic practice. PATIENTS AND METHODS: Records of...
Na minha lista:
| Publicado no: | Clin Med Insights Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6354297/ https://ncbi.nlm.nih.gov/pubmed/30728734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179554918825447 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|